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Currently scientiﬁc and public concern exists
about persistent organic chemicals, such as
polychlorinated biphenyls (PCBs), dichlorodi-
phenyltrichloroethane (DDT), and dichloro-
diphenyldichloroethylene (DDE, the most
stable daughter compound of DDT). Several
researchers have hypothesized that these com-
pounds may be associated with the suggested,
although not conﬁrmed, downward trend in
semen parameters (Irvine et al. 1996; Sharpe
and Skakkebaek 1993). The concern stems
from studies showing that PCBs and p,p´-DDE
are found in a large proportion of the general
population (CDC 2003; Longnecker et al.
1997; Murphy and Harvey 1985; Stehr-Green
1989) and from animal and limited human
studies suggesting possible associations of
exposure to PCBs and p,p´-DDE with semen
abnormalities (Bush et al. 1986; Dallinga et al.
2002; Richthoff et al. 2003). Serum levels of
PCBs and p,p´-DDE are an integrated measure
of internal dose, reflecting exposure from all
sources over the previous years; depending on
congener type, the half-lives of PCBs in the
blood range from 1 to 10 or more years,
whereas p,p´-DDE has a half-life of 10 or more
years (Brown 1994; Phillips et al. 1989b).
PCBs and p,p´-DDE are persistent lipo-
philic chemicals. DDT was widely used as an
insecticide, whereas PCBs were used in cutting
oils and lubricants and as electrical insulators.
Although their use and manufacture were
banned nearly 30 years ago, they are ubiquitous
and persist in the environment. They are dis-
tributed worldwide as environmental pollutants
and have been measured in air, water, aquatic
and marine sediments, ﬁsh, and wildlife (De
Voogt and Brinkman 1989). Furthermore,
they are biologically concentrated and stored in
human adipose tissue. The general population
continues to be exposed to PCBs and p,p´-
DDE through ingestion of contaminated foods
(fish, meat, eggs, and dairy products) and
water, as well as through dermal contact (soil
and house dust) and inhalation (indoor air in
buildings that have various sources, as well as
outdoor air).
Studies suggest that there is a temporal
downward trend in human semen quality
(Auger et al. 1995; Carlsen et al. 1992;
Giwercman et al. 1993; Irvine et al. 1996;
Swan et al. 1997, 2000). However, other stud-
ies suggest that semen quality has not declined
or may have even increased marginally (Bujan
et al. 1996; Fisch et al. 1996; Paulsen et al.
1996; Sherins 1995). Nevertheless, most of
these studies suggest that semen quality varies
by geographic location (Fisch and Goluboff
1996). It has been hypothesized that the
geographic variation in semen quality may be
caused by environmental exposures, lifestyle
factors, or some unknown cause(s) (Fisch and
Goluboff 1996). However, the temporal trend
studies lacked information at the individual
level on lifestyle factors, such as cigarette
smoking, as well as information on exposure
to potential environmental contaminants,
such as PCBs and DDT (Sun et al. 1996;
Vine et al. 1994).
To determine whether environmental
levels of PCBs and p,p´-DDE are associated
with altered semen parameters in adult men,
we selected a study population without spe-
ciﬁc exposure to these compounds. Detecting
even an association of small magnitude may
have large public health signiﬁcance because
of the widespread distribution of PCBs and
p,p´-DDE in the general population.
Materials and Methods
Subjects. The study was approved by the
Harvard School of Public Health and
Massachusetts General Hospital (MGH)
Human Subjects Committees, and all subjects
signed an informed consent. Subjects were
male partners of subfertile couples who pre-
sented to the Vincent Burnham Andrology
Laboratory at MGH between January 2000
and October 2001 for semen analysis.
Individual men may or may not have been
infertile. Sixty-six percent of eligible men
between 20 and 54 years old agreed to partici-
pate. Men presenting for postvasectomy
semen analysis and men receiving treatment
for infertility, such as hormonal treatments,
were excluded. Height and weight were mea-
sured, and a questionnaire was used to collect
information on medical history and lifestyle
factors.
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Scientiﬁc and public concern exists about potential reproductive health effects of persistent chlori-
nated organic chemicals, such as polychlorinated biphenyls (PCBs), dichlorodiphenyltrichloroethane
(DDT), and dichlorodiphenyldichloroethylene (DDE, the most stable daughter compound of DDT).
To explore the hypothesis that environmental exposures to PCBs and DDE are associated with altered
semen parameters, we conducted a cross-sectional study of 212 male partners of subfertile couples
who presented to the Massachusetts General Hospital Andrology Laboratory. Semen parameters were
analyzed as both a continuous measure and dichotomized based on World Health Organization refer-
ence values for sperm concentration (< 20 million/mL), motility (< 50% motile), and Kruger strict
criteria for morphology (< 4% normal). The comparison group for the dichotomized analysis was
men with all three semen parameters above the reference values. In serum, 57 PCB congeners and
p,p´-DDE were measured by congener-speciﬁc analysis using gas chromatography with electron cap-
ture detection. There were dose–response relationships among PCB-138 and sperm motility (odds
ratio per tertile, adjusted for age, abstinence, and smoking, and p-value for trend were, respectively,
1.00, 1.68, 2.35, and p-value = 0.03) and morphology (1.00, 1.36, 2.53, p-value = 0.04). There was
limited evidence of an inverse relationship between sum of PCBs, as well as those PCBs classiﬁed as
cytochrome P450 enzyme inducers, with sperm motility and sperm morphology, as well as limited
evidence of an inverse association between p,p´-DDE and sperm motility. The lack of a consistent
relationship among semen parameters and other individual PCB congeners and groupings of con-
geners may indicate a difference in spermatotoxicity between congeners. Key words: DDT, environ-
mental health, polychlorinated biphenyls, reproductive health, semen, sperm. Environ Health Perspect
111:1505–1511 (2003). doi:10.1289/ehp.6175 available via http://dx.doi.org/ [Online 19 May 2003]
Environmental Medicine | ArticleSemen analysis. Each man produced a
single semen sample by masturbation into a
sterile plastic specimen cup. The sample was
liqueﬁed at 37°C for 20 min before analysis.
Subjects were instructed to abstain from ejac-
ulation for 48 hr before producing the semen
sample and to complete a questionnaire on
the length of the sexual abstinence period.
Semen analyses were performed without
knowledge of subjects’ PCB and p,p´-DDE
levels. All semen samples were analyzed for
sperm concentration and motion parameters
by computer-aided sperm analysis (CASA; ver-
sion 10HTM-IVOS, Hamilton-Thorn,
Beverly, MA). Setting parameters and the deﬁ-
nition of measured sperm motion parameters
for CASA were established by Hamilton-
Thorn (frames acquired, 30; frame rate, 60 Hz;
straightness threshold, 80.0%; medium average
path velocity cutoff, 25.0 µm/sec; duration of
the tracking time, 0.38 sec). To measure both
sperm concentration and motility, we placed
aliquots of semen samples (5 µL) into a pre-
warmed (37°C) Makler counting chamber
(Sefi Medical Instruments, Haifa, Israel). A
minimum of 200 sperm from at least four dif-
ferent fields were analyzed from each speci-
men. Percent motile sperm was defined as
World Health Organization (WHO) “A”
grade sperm (rapidly progressive with a veloc-
ity ≥ 25 µm/sec at 37°C) plus “B” grade sperm
(slow/sluggish progressive with a velocity
<5µm/sec but < 25 µm/sec).
Using the “feathering” method from the
WHO (1999), we made at least two slides
for each fresh semen sample. The resulting
thin smear was allowed to air dry for 1 hr
before staining with a Diff-Quik staining kit
(Dade Behring AG, Düdingen, Switzerland).
Morphologic assessment was performed with
a Nikon microscope using an oil immersion
100× objective (Nikon Company, Tokyo,
Japan). Spermatozoa were assessed and scored
as normal or abnormal using the strict criteria
of Kruger et al. (1998). A minimum of 200
spermatozoa were counted from two slides for
each specimen. Results were expressed as the
percentage of normal spermatozoa.
Serum PCB and p,p´-DDE measurements.
Blood samples were collected on the same day
as the semen sample and analyzed by the
Organic Chemistry Analytical Laboratory at
the Harvard School of Public Health. Target
analytes included 57 individual PCB congeners
and p,p´-DDE. Details of the sampling, analyt-
ical, and quality control (QC) procedures are
described elsewhere (Korrick et al. 2000).
Briefly, the blood samples were collected in
red-top Vacutainer tubes, and the serum frac-
tion was separated by centrifugation. Serum
samples were stored in solvent rinsed glass vials
with Teﬂon-lined caps at –80°C until analysis.
For extraction, we used procedures devel-
oped by the Centers for Disease Control
(Needham 1981) with modiﬁcations to con-
form to ultra-trace-level analyses. These mod-
ifications included additional cleaning of
glassware and dry reagents used in the column
chromatography cleanup, and reducing the
ﬁnal extract volume to 100 µL.
Because PCBs and p,p´-DDE partition
according to the lipid content of tissues, and
serum lipid levels vary between fasting and
nonfasting states, a correction for serum lipids
is needed for the valid interpretation of serum
levels (Phillips et al. 1989a). Therefore, percent
lipid for each serum sample was measured gravi-
metrically, by weighing an aliquot of sample
extract evaporated to dryness. The mean (SD)
for the 212 samples was 0.51% (0.20) lipid.
The serum extracts were analyzed by GC
with electron capture detection (ECD) using
a Hewlett-Packard 5890 Series II GC with a
fused silica capillary column (DB5, 30 m,
0.25 mm, 0.25 µm; J&W Scientiﬁc, Folsom,
CA). Conﬁrmatory analysis was done using a
Hewlett-Packard 6980 GC with a Micro-
ECD (GC/µECD) and capillary column of
different polarity. Quantitation was based on
the response factors of individual PCB con-
geners and p,p´-DDE relative to the internal
standard (PCB-166 by International Union
for Pure and Applied Chemistry nomencla-
ture; Ballschmiter et al. 1992). PCB concen-
trations were reported as individual congeners
and as the sum of all congeners assayed
(ΣPCB). The amount of each PCB congener
in samples was corrected by the amount of
that analyte in the procedural blank associated
with the analytical batch. Results were not
adjusted for surrogate recoveries.
The PCB and p,p´-DDE concentrations
were adjusted for total serum lipids and are
expressed in units of ng/g total lipids. PCB con-
geners 118, 138, and 153, as well as p,p´-DDE,
were especially of interest because they are
prevalent in human serum and because the lim-
ited human data suggest that they may be asso-
ciated with altered sperm motility (Ayotte et al.
2001; Bush et al. 1986; Dallinga et al. 2002).
Quality assurance and QC. The Organic
Chemistry Analytical Laboratory follows strict
QC and quality assurance (QA) procedures.
The laboratory successfully participates in vari-
ous intercalibration exercises, including an
international intercomparison program orga-
nized by the Institute for Quality Management
and Medicine, at the University of Erlangen-
Nuremberg, Germany (annually), and the
international Ring tests sponsored by the
Arctic Monitoring and Assessment Program
and organized by Quebec National Institute of
Public Health, Canada (three times per year).
Method detection limit (MDL) values
were determined as three times the SD
obtained from the analysis of the eight aliquots
of pooled serum fortiﬁed with target analytes at
0.02 ng/g serum, as recommended by U.S.
Environmental Protection Agency methods
(U.S. EPA 1984). The MDL values for all
PCB congeners were < 0.05 ng/g, with most
of the congeners < 0.01 ng/g. The MDL for
p,p´-DDE was higher, but only because
unfortified serum had high p,p´-DDE con-
centrations at 6.3 ng/g.
Background contamination in 13 analyti-
cal batches was determined by procedural
blanks. The mean (SD) for ΣPCB was 0.18
(0.02) ng/g. Analytical accuracy, precision,
and extraction efﬁciency were evaluated by the
analyses of two pairs (one pair in each batch)
of matrix spike samples (aliquots of pooled
bovine serum spiked at 0.24 ng/g of each PCB
congener, 0.13 ng/g of p,p´-DDE) and two
surrogate compounds, PCB-30 and PCB-112,
added to each sample at 0.67 ng/g. The mean
(SD) percent recovery for matrix spike samples
was 95% (6.6) for ΣPCB and 99% (10) for
DDE. The mean (SD) percent recovery for
two surrogate compounds, PCB-30 and
PCB-112, was 96% (6.8) and 98% (4.1),
respectively. Precision, expressed as mean rela-
tive percent difference between ΣPCBs in
matrix spike duplicates, was 5.5% (4.8).
Statistical analysis. Statistical Analysis
Software (SAS), version 8.2 (SAS Institute Inc.,
Cary, NC), was used for data analysis. On the
basis of earlier studies (Bush et al. 1986;
Dallinga et al. 2002; Richthoff et al. 2003), we
explored the relationship between semen para-
meters and three individual PCB congeners
(PCBs 118, 138, and 153), as well as ΣPCBs.
Analyses using the other individual PCB con-
geners were not conducted. In addition, an
analysis of the relationship between semen
parameters and groupings of PCBs, based on
structural and biological activity as proposed
by Wolff et al. (1997), was conducted. PCBs
were grouped as follows: group 1, potentially
estrogenic and weak phenobarbitol inducers
(congeners 44, 49, 52, 101, 187, 174, 177,
157/201); group 2, potentially antiestrogenic
and dioxin-like (congeners 95/66, 74, 77/110,
105/141, 118, 156, 167, 128, 138, 170); and
group 3, phenobarbital, CYP1A, and CYP2B
inducers (congeners 99, 153, 180, 196/203,
183). Relationships between semen parameters
and p,p´-DDE were also explored.
Because the distributions of the PCBs and
p,p´-DDE were not normally distributed, non-
parametric methods (Spearman correlation
coefficients or Wilcoxon signed rank tests)
were used to explore their relationships with
age, body mass index (BMI), smoking status,
and race. Chi-square tests were used to explore
the relationships between categorical semen
parameters and categorical covariates, such as
abstinence time, race, and smoking status.
In preliminary analyses, we used scatter-
plots and multiple linear regression to explore
the relationships among semen parameters
and PCBs and p,p´-DDE. Because sperm
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residuals were not normally distributed, they
were log-transformed after a small positive
number was added (Berman et al. 1996). For
our primary analyses, we conducted multivari-
ate logistic regression analyses in which semen
parameters were dichotomized based on
WHO (1999) reference values for sperm con-
centration (< 20 million/mL) and motility
(< 50% motile sperm) and Kruger strict crite-
ria for morphology (< 4% normal sperm). The
comparison group was deﬁned as men with all
three semen parameters at or above the refer-
ence value. In these analyses, we divided PCBs
and p,p´-DDE into tertiles, which were used
as dummy variables to allow for the explo-
ration of nonlinear relationships. A separate
multivariate logistic regression model was used
for each semen parameter. Individuals whose
values were above the WHO reference value
on the semen parameter of interest, but below
the WHO reference value on one or both of
the other two semen parameters, were
excluded from the analysis on the semen para-
meter of interest. For instance, in the logistic
regression analysis on the relationship between
sperm concentration and organochlorines,
men with sperm concentrations below refer-
ence were considered “cases,” whereas men
with all three semen parameters above the ref-
erence value were considered “comparison”
subjects. Men with sperm concentration above
the reference value, but with motility and/or
morphology below the reference value, were
excluded from this speciﬁc analysis.
Covariates considered for inclusion in the
multivariate regression and logistic models
included smoking status, race, age, BMI, and
abstinence time. Their final inclusion in the
multivariate models was based on statistical
and biologic considerations (Hosmer and
Lemeshow 1989). Age was modeled as a con-
tinuous independent variable. Abstinence time
was modeled as an ordinal ﬁve-category vari-
able (≤ 2, 3, 4, 5, and ≥ 6 days). Smoking sta-
tus was included as a dummy variable (current
and former vs. never).
Results
Of the 212 men (66% participation) in the
study population, 40 (19%) had a sperm con-
centration < 20 million/mL, 97 men (46%)
had < 50% motile sperm, and 58 men (27%)
had < 4% normally shaped sperm. Ninety-
eight (46%) men had values above reference
on all three semen parameters. The semen
parameter categories were not mutually exclu-
sive: A man could contribute data to any one,
two, or all three of the below-reference-value
groups. Overall, the subjects were primarily
Caucasian (79%), with 6% African American
and 8% Hispanic. The mean (SD) age was
36.0 (5.4) years. Seventy-three percent had
never smoked.
The demographic distribution, by semen
parameter, is summarized in Table 1. Advanced
age and Hispanic ethnic origin were predictors
of one or more below-reference semen parame-
ters, whereas current cigarette smoking was not
strongly associated with below-reference semen
parameters. However, only eight men in the
comparison group were current smokers, which
limited the ability to investigate the relationship
between smoking and semen quality. As
expected, men who had a previous examination
for infertility were more likely to be below the
reference value on all three semen parameters.
We measured 57 PCB congeners and
p,p´-DDE. There was a wide distribution of
both the PCB congeners and p,p´-DDE con-
centrations (Table 2). The median p,p´-DDE
concentration was 222 ng/g lipids, with a range
from 64.2 to 8,912 ng/g lipid. The median of
ΣPCBs was 216 ng/g lipid and ranged from
56.0 to 1,733 ng/g lipid. The levels of
p,p´-DDE in serum were higher than the levels
of individual PCB congeners, which is also con-
sistent with other studies (Bush et al. 1986).
Associations described previously among
ΣPCBs and speciﬁc PCB congeners were con-
ﬁrmed in these analyses (De Voto et al 1997;
Koopman-Esseboom et al. 1994). Strong cor-
relations were observed between ΣPCBs with
PCB congeners 153 and 138, and with the
three groupings of PCBs (r > 0.9, p-values
< 0.0001). There was a moderate correlation
between ΣPCBs and PCB-118 (r = 0.6, p-value
< 0.0001). The three groupings of PCB con-
geners were strongly correlated with each other
(r > 0.8, p-values < 0.0001). Among the indi-
vidual congeners, PCB-153 and PCB-138 were
strongly correlated (r = 0.9, p-value < 0.0001),
whereas PCB-118 was moderately correlated
with PCB-153 and PCB-138 (r = 0.6 and 0.7,
Environmental Medicine | Organochlorines and human semen parameters
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Table 1. Demographic and medical history by semen parameters (n = 212).
Sperm Sperm Sperm
Comparison concentration motility morphology
subjectsa (< 20 million/mL) (< 50% motile) (< 4% normal)
(n = 98) (n = 40)b (n = 97)b (n = 58)b
Age (mean ± SD) 35.3 ± 5.1 36.5 ± 6.0 36.9 ± 5.7* 36.3 ± 5.3
Abstinence timec [n (%)]
≤ 2 days 25 (25.8) 10 (25.0) 25 (25.8) 10 (17.2)
3 days 33 (34.0) 9 (22.5) 30 (30.9) 18 (31.0)
4 days 14 (14.4) 9 (22.5) 17 (17.5) 11 (19.0)
5 days 11 (11.3) 4 (10.0) 7 (7.2) 4 (6.9)
≥ 6 days 14 (14.4) 8 (20.0) 18 (18.6) 15 (25.9)
Racec [n (%)]
White 82 (83.7) 29 (74.4) 68 (71.6)* 44 (77.2)
African American 5 (5.1) 3 (7.7) 8 (8.4) 4 (7.0)
Hispanic 4 (4.1) 3 (7.7) 12 (12.6)* 5 (8.8)
Other 7 (7.1) 4 (10.3) 7 (7.4) 4 (7.0)
Smoking statusc [n (%)]
Never smoker 73 (74.5) 26 (66.7) 67 (69.8) 39 (68.4)
Ever smoker 25 (25.5) 13 (33.3) 29 (30.2) 18 (31.6)
Current smoker 8 (8.2) 5 (12.8) 10 (10.4) 5 (8.8)
Ex-smoker 17 (17.4) 8 (20.5) 19 (19.8) 13 (22.8)
Previous exam for infertility [n (%)] 19 (19.4) 19 (48.7)* 41 (42.7)* 24 (42.4)*
Wilcoxon signed rank tests were used for age comparisons across semen parameter groups. Chi-square tests were used
for comparisons of categorical variables across semen parameter groups.
aSubjects with sperm concentration ≥ 20 million/mL, motility ≥ 50% motile, and morphology ≥ 4% normal. bA subject may
contribute data to more than one category. cRace information missing on two men, smoking missing on one, and abstinence
data missing on one. *p-Value < 0.05 compared with comparison group.
Table 2. Distribution of serum levels of p,p´-DDE, PCB-118, PCB-138, PCB-153, and ΣPCBs (n = 212).
Percentile
Minimum 5th 25th 50th 75th 95th Maximum Geometric mean
p,p´-DDE 64.2 93.6 157.0 222.2 374.7 1648.2 8911.8 275.3
PCB-118 3.1 5.3 7.8 12.0 18.7 35.7 61.5 12.6
PCB-138 7.3 14.1 22.3 31.2 47.4 102.3 295.4 33.6
PCB-153 9.3 19.5 29.0 41.8 61.1 128.0 361.3 43.8
ΣPCB 56.0 116.0 152.7 215.9 306.6 568.1 1732.6 226.2
ΣEstrogenic PCBs (group 1) 3.9 7.4 10.9 15.7 22.1 43.2 204.8 16.4
ΣDioxin-like PCBs (group 2) 19.6 38.1 55.0 74.0 116.1 227.7 518.5 81.8
ΣEnzyme-inducing PCBs (group 3) 19.7 40.4 61.1 88.8 132.6 267.7 829.6 92.9
All serum levels are adjusted for lipids and expressed as ng/g lipids.respectively, p-values < 0.0001). There were
weak to moderate correlations between
p,p´-DDE with PCB congeners 153, 138, and
118 and ΣPCBs (0.3 < r < 0.4, p-values
< 0.0001).
There were weak to moderate correlations
between age and ΣPCBs, groupings of PCBs,
and PCB-138 and PCB-153 (0.3 < r < 0.4,
p-values < 0.0001), and between p,p´-DDE
and age (r = 0.24, p-value = 0.0004). There
were weak and nonsignificant relationships
between BMI and the PCBs, and a weak
inverse signiﬁcant relationship between BMI
and p,p´-DDE (r = –0.1, p-value = 0.05).
Except for PCB-118, there were nonsigniﬁcant
relationships between smoking status and
PCBs. For current smokers, the median con-
centration of PCB-118 was 7.8 ng/g lipid,
compared with 13.1 ng/g lipid and 12.0 ng/g
lipid for ex-smokers and never smokers, respec-
tively. Hispanics had lower PCB concentra-
tions, but higher p,p´-DDE concentrations,
than did Caucasians. For Hispanics, the
median concentration of ΣPCBs and p,p´-DDE
was 143 ng/g lipid and 666 ng/g lipid, respec-
tively, compared with 220 ng/g lipid and
204 ng/g lipid, respectively, for Caucasians.
African Americans also had signiﬁcantly higher
p,p´-DDE, 370 ng/g lipid, compared with
Caucasians, but PCB concentrations in African
Americans did not differ with those measured
in Hispanics and Caucasians.
In the multivariate analyses, age, smoking
status, and abstinence time were included in
each model because they are considered predic-
tors of semen quality (Blackwell and Zaneveld
1992; Kidd et al. 2001; Vine et al. 1994). BMI
was not included in the models because it was
weakly associated with PCBs and p,p´-DDE
and was not a known predictor of semen para-
meters. Crude and adjusted odds ratios (ORs)
for below-reference-value semen parameters by
tertiles of PCBs and p,p´-DDE are presented in
Tables 3–5. In the adjusted analyses, there were
signiﬁcant dose–response relationships (OR per
tertile adjusted for age, abstinence, and smok-
ing) between PCB-138 and below-reference-
value sperm motility (1.00, 1.68, 2.35,
respectively; p-value for trend = 0.03) and
below-reference-value sperm morphology
(1.00, 1.36, 2.53, p-value for trend = 0.04).
There was a nonsigniﬁcant dose–response rela-
tionship for PCB-138 and below-reference-
value sperm concentration (1.00, 1.72, 1.62,
p-value for trend = 0.3). The crude ORs for
PCB-138 were larger than the adjusted ORs.
Furthermore, the crude ORs for the relation-
ship between sperm motility and PCB-153 and
ΣPCBs (respectively: 1.00, 1.10, 1.86, p-value
for trend = 0.08; 1.00 1.77, 1.88, p-value for
trend = 0.08) showed a stronger dose–response
trend than did the adjusted dose–response rela-
tionships. Although not statistically signiﬁcant,
p,p´-DDE showed a weak dose–response trend
with below-reference-value sperm motility
(1.00, 1.14, 1.51, p-value for trend = 0.3).
Crude and adjusted ORs for below-refer-
ence-value semen parameters by tertiles of
groupings of PCBs are presented in Tables
6–8. There were dose–response relationships
(OR per tertile adjusted for age, abstinence,
and smoking) between PCB congeners in
group 3 (cytochrome P450 enzyme inducers)
and below-reference-value sperm motility
(1.00, 1.56, 1.80, p-value for trend = 0.1) and
below-reference-value sperm morphology
(1.00, 1.33, 1.93, p-value for trend = 0.1)
(Tables 7 and 8, respectively). The crude analy-
sis showed a stronger and statistically signiﬁcant
dose–response trend for the relationship
between group-3 PCBs and below-reference-
value sperm motility and morphology (respec-
tively: 1.00, 1.71, 2.12, p-value for trend = 0.04;
1.00, 1.59, 2.23, p-value for trend = 0.05). For
the other two PCB groupings (group 1, poten-
tially estrogenic; group 2, potentially antiestro-
genic and dioxin-like), the ORs for the third
tertile were increased for below-reference-value
sperm motility and morphology, but there was
limited evidence of a trend.
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Table 3. Crude and adjusted ORs (95% CI) for below reference value sperm concentration (SC)a by tertiles
of p,p´-DDE and PCBs.
p,p´-DDE and PCB tertiles p-Value
Tertile 1 Tertile 2 Tertile 3 for trend
p,p´-DDE
SC < 20 million/mL (n)1 5 1 11 4
Crude OR (95% CI) 1.00 0.73 (0.30–1.83) 1.06 (0.44–2.55) 0.9
Adjusted OR (95% CI)b 1.00 0.64 (0.24–1.70) 0.96 (0.37–2.51) 0.9
PCB-118
SC < 20 million/mL (n)1 3 1 61 1
Crude OR (95% CI) 1.00 1.09 (0.45–2.62) 0.82 (0.32–2.10) 0.7
Adjusted OR (95% CI)b 1.00 1.01 (0.39–2.66) 0.78 (0.28–2.13) 0.6
PCB-138
SC < 20 million/mL (n)1 1 1 51 4
Crude OR (95% CI) 1.00 1.71 (0.69–4.22) 1.96 (0.77–4.97) 0.1
Adjusted OR (95% CI)b 1.00 1.72 (0.68–4.38) 1.62 (0.59–4.46) 0.3
PCB-153
SC < 20 million/mL (n)1 4 1 01 6
Crude OR (95% CI) 1.00 0.74 (0.29–1.87) 1.52 (0.64–3.65) 0.4
Adjusted OR (95% CI)b 1.00 0.58 (0.21–1.60) 1.24 (0.47–3.24) 0.7
ΣPCB congeners
SC < 20 million/mL (n)1 4 1 31 3
Crude OR (95% CI) 1.00 1.18 (0.48–2.88) 1.18 (0.48–2.88) 0.7
Adjusted OR (95% CI)b 1.00 1.00 (0.39–2.60) 0.89 (0.33–2.38) 0.8
Tertile cut points (ng/g lipid): p,p´-DDE: 64.2–184.3, 184.9–296.6, 302.5–8911.8; PCB-118: 3.1–9.1, 9.2–16.3, 16.5–61.5; PCB-
138: 7.3–24.9, 25.0–38.5, 39.3–295.4; PCB-153: 9.3–32.3, 32.4–52.9, 53.5–361.3; ΣPCBs: 56.0–175.1, 177–260.8, 265.1–1732.6.
aBelow reference value for sperm concentration (SC) was deﬁned as < 20 million sperm/mL. bAdjusted for age (continuous),
abstinence time (ﬁve categories: ≤ 2, 3, 4, 5, and ≥ 6 days) and smoking (current, former, and never).
Table 4. Crude and adjusted ORs (95% CI) for below reference value sperm motility (SM)a by tertiles of
p,p´-DDE and PCBs.
p,p´-DDE and PCB tertiles p-Value
Tertile 1 Tertile 2 Tertile 3 for trend
p,p´-DDE
SM < 50% motile (n)2 7 3 1 3 9
Crude OR (95% CI) 1.00 1.15 (0.57–2.32) 1.64 (0.82–3.28) 0.2
Adjusted OR (95% CI)b 1.00 1.14 (0.55–2.35) 1.51 (0.73–3.13) 0.3
PCB-118
SM < 50% motile (n)3 3 3 0 3 4
Crude OR (95% CI) 1.00 0.81 (0.40–1.61) 1.00 (0.50–1.99) 1.00
Adjusted OR (95% CI)b 1.00 0.75 (0.36–1.55) 0.94 (0.46–1.94) 0.9
PCB-138
SM < 50% motile (n)2 4 3 3 4 0
Crude OR (95% CI) 1.00 1.72 (0.85–3.47) 2.56 (1.26–5.20) 0.009
Adjusted OR (95% CI)b 1.00 1.68 (0.82–3.42) 2.35 (1.11–4.99) 0.03
PCB-153
SM < 50% motile (n)2 8 3 0 3 9
Crude OR (95% CI) 1.00 1.10 (0.55–2.21) 1.86 (0.93–3.73) 0.08
Adjusted OR (95% CI)b 1.00 0.93 (0.45–1.94) 1.60 (0.75–3.41) 0.2
ΣPCB congeners
SM < 50% motile (n)2 5 3 5 3 7
Crude OR (95% CI) 1.00 1.77 (0.88–3.58) 1.88 (0.93–3.77) 0.08
Adjusted OR (95% CI)b 1.00 1.54 (0.74–3.22) 1.60 (0.76–3.39) 0.2
Tertile cut points (ng/g lipid): p,p´-DDE: 64.2–184.3, 184.9–296.6, 302.5–8911.8; PCB-118: 3.1–9.1, 9.2–16.3, 16.5–61.5; PCB-
138: 7.3–24.9, 25.0–38.5, 39.3–295.4; PCB-153: 9.3–32.3, 32.4–52.9, 53.5–361.3; ΣPCBs: 56.0–175.1, 177–260.8, 265.1–1732.6.
aBelow reference value for sperm motility (SM) was deﬁned as < 50% motile sperm. bAdjusted for age (continuous), absti-
nence time (ﬁve categories: ≤ 2, 3, 4, 5, and ≥ 6 days) and smoking (current, former, and never).The interpretation of the results from the
multivariate regression analyses, in which
semen parameters and PCBs and p,p´-DDE
were used as continuous measures, was gener-
ally similar to that for the logistic regression
analyses. After adjustment for age, abstinence
time, and smoking status, there was a statisti-
cally significant inverse relationship between
log-transformed sperm concentration and
PCB-138 [β = –24.8 million sperm per
mL/interquartile range (IQR); 95% confi-
dence interval (95% CI), –24.6 to –25.0; p <
0.008), and an inverse, although not statisti-
cally significant, relationship between PCB-
138 and motility (β = –1.8% motility/IQR;
95% CI, –4.4 to 0.87; p = 0.2) and morphol-
ogy (β = –0.28% morphology/IQR; 95% CI,
–0.78 to 0.23; p = 0.3). In comparison, in the
logistic regression analyses, PCB-138 was
statistically significantly inversely associated
with sperm motility and morphology but non-
significantly inversely associated with sperm
concentration. Although statistical signiﬁcance
does differ, the dose–response relationships
from the logistic and regression analyses con-
sistently show inverse relationships between
PCB-138 and semen parameters. The rela-
tionships observed between semen parameters
and p,p´-DDE and individual PCB congeners,
ΣPCBs, and groupings of PCBs were consis-
tent with the interpretation of the results of
the logistic regression analyses.
We conducted sensitivity analyses after
excluding nine men with azoospermia to pre-
vent undue statistical inﬂuence from extreme
sperm counts (i.e., zero) and because the mecha-
nism responsible for azoospermia may be related
to an obstructive mechanism or Y-chromosome
deletions. In the reanalysis, the results remained
essentially unchanged (data not shown).
Discussion
In the present study, we found dose–response
relationships between PCB-138 and decreased
sperm concentration, sperm motility, and poor
sperm morphology measured using the strict
criteria. There were inverse, although non-
signiﬁcant, relationships of ΣPCBs and group
3 PCBs (enzyme inducers) with sperm motil-
ity and sperm morphology. Group 3 did not
include PCB-138, which was in group 2.
There was weak evidence of an association
between p,p´-DDE and sperm motility.
Overall, these results suggest that individual
congeners and groupings of congeners based
on structure–activity may represent a more
appropriate approach to the analysis between
PCBs and health end points. As widely dis-
cussed in the literature, individual congeners
have different toxicities and biologic activities
(Ahlborg et al. 1994; Hansen 1999; Safe 1990,
1993). Depending on the number and pattern
of the chlorine substitutions, the biologic activ-
ity of individual PCB congeners will vary.
Therefore, in addition to conducting analyses
using individual PCB congeners and ΣPCBs,
we used congener groupings based on both
structure and potential biologic activity based
on groupings proposed by Wolff et al. (1997).
Although these groupings represent an improve-
ment in exposure classiﬁcation compared with
earlier studies that only used ΣPCBs, they still
have several limitations. For instance, within
groups, congeners are summed using concentra-
tion, but no weighting factor is applied to
account for differential activities. In addition,
these groupings are based on PCB activity in
animal and in vitro systems, and not in
humans. Finally, the groupings are not based
specifically on potential testicular toxicity in
animals or humans, but rather on general
potential biologic activity. These limitations
will contribute to exposure misclassiﬁcation of
the groupings of PCBs. Although the direction
of the misclassiﬁcation bias is unknown, it is
generally expected to bias toward the null
hypothesis.
Some animal data suggest that PCBs and
p,p´-DDE may be hormonally active and
therefore adversely affect semen parameters.
These compounds, which readily penetrate
the blood–testis barrier, may directly affect
spermatogenesis (Bush et al. 1986; Tuohimaa
and Wichmann 1985). Effects at the mitotic
or meiotic level may lead to decreased sperm
production, whereas the targeting of postmei-
otic processes and epididymal sperm matura-
tion may lead to impaired sperm motility.
The estrogen-like characteristics of specific
PCBs are supported by evidence showing that
PCB metabolites bind to estrogen receptors
(Korach et al. 1988). Jansen et al. (1993)
hypothesized that the adverse reproductive
effects of PCBs may result from PCB congeners
increasing gonadotropin-releasing hormone or
Environmental Medicine | Organochlorines and human semen parameters
Environmental Health Perspectives • VOLUME 111 | NUMBER 12 | September 2003 1509
Table 5. Crude and adjusted ORs (95% CI) for below reference value sperm morphology (SMPH)a by tertiles
of p,p´-DDE and PCBs.
p,p´-DDE and PCB tertiles p-Value
Tertile 1 Tertile 2 Tertile 3 for trend
p,p´-DDE
SMPH < 4% normal (n)1 7 2 4 1 7
Crude OR (95% CI) 1.00 1.41 (0.65–3.09) 1.13 (0.49–2.61) 0.8
Adjusted OR (95% CI)b 1.00 1.28 (0.56–2.93) 1.14 (0.47–2.80) 0.8
PCB-118
SMPH < 4% normal (n)1 7 2 0 2 1
Crude OR (95% CI) 1.00 1.04 (0.47–2.34) 1.20 (0.53–2.69) 0.7
Adjusted OR (95% CI)b 1.00 0.94 (0.40–2.25) 1.10 (0.47–2.61) 0.8
PCB-138
SMPH < 4% normal (n)1 5 1 7 2 6
Crude OR (95% CI) 1.00 1.42 (0.61–3.27) 2.67 (1.19–5.96) 0.02
Adjusted OR (95% CI)b 1.00 1.36 (0.57–3.22) 2.53 (1.06–6.03) 0.04
PCB-153
SMPH < 4% normal (n)1 8 1 5 2 5
Crude OR (95% CI) 1.00 0.86 (0.37–1.96) 1.85 (0.85–4.06) 0.1
Adjusted OR (95% CI)b 1.00 0.65 (0.26–1.59) 1.64 (0.69–3.86) 0.2
ΣPCB congeners
SMPH < 4% normal (n)1 7 1 7 2 4
Crude OR (95% CI) 1.00 1.27 (0.56–2.89) 1.79 (0.82–3.92) 0.1
Adjusted OR (95% CI)b 1.00 1.02 (0.42–2.45) 1.56 (0.67–3.63) 0.3
Tertile cut points (ng/g lipid): p,p´-DDE: 64.2–184.3, 184.9–296.6, 302.5–8911.8; PCB-118: 3.1–9.1, 9.2–16.3, 16.5–61.5; PCB-
138: 7.3–24.9, 25.0–38.5, 39.3–295.4; PCB-153: 9.3–32.3, 32.4–52.9, 53.5–361.3; ΣPCBs: 56.0–175.1, 177–260.8, 265.1–1732.6.
aBelow reference value for morphology (SMPH) was deﬁned as < 4% normally shaped sperm. bAdjusted for age (continuous),
abstinence time (ﬁve categories: ≤2, 3, 4, 5, and ≥6 days) and smoking (current, former, and never).
Table 6. Crude and adjusted ORs (95% CI) for below reference value sperm concentration (SC)a by tertiles
of grouped PCBs.
Tertiles of PCB congener groupings p-Value
Tertile 1 Tertile 2 Tertile 3 for trend
ΣEstrogenic PCBs (group 1)
SC < 20 million/mL (n)1 2 1 5 1 3
Crude OR (95% CI) 1.00 1.45 (0.59–3.56) 1.26 (0.50–3.16) 0.6
Adjusted OR (95% CI)b 1.00 1.47 (0.57–3.76) 1.01 (0.37–2.76) 0.9
ΣDioxin-like PCBs (group 2)
SC < 20 million/mL (n)1 2 1 4 1 4
Crude OR (95% CI) 1.00 1.17 (0.47–2.88) 1.46 (0.58–3.65) 0.4
Adjusted OR (95% CI)b 1.00 1.05 (0.41–2.71) 1.22 (0.46–3.25) 0.7
ΣEnzyme-inducing PCBs (group 3)
SC < 20 million/mL (n)1 3 1 2 1 5
Crude OR (95% CI) 1.00 1.16 (0.47–2.90) 1.61 (0.66–3.90) 0.3
Adjusted OR (95% CI)b 1.00 1.06 (0.41–2.76) 1.23 (0.46–3.32) 0.7
Tertile cut points (ng/g lipid): ΣEstrogenic PCBs: 3.9–12.5, 12.6–19.4, 19.5–204.8; ΣDioxin-like PCBs: 19.6–61.0, 61.4–94.1,
94.9–518.5; ΣEnzyme-inducing PCBs: 19.7–68.6, 69.7–111.1, 114.5–829.6.
aBelow reference value for sperm concentration (SC) was deﬁned as < 20 million sperm/mL. bAdjusted for age (continuous),
abstinence time (ﬁve categories: ≤ 2, 3, 4, 5, and ≥ 6 days) and smoking (current, former, and never).affecting production and release of luteinizing
hormone from the pituitary. Kelce et al. (1995)
showed that p,p´-DDE has antiandrogenic and
estrogenic properties and may affect spermato-
genesis through its antiandrogen activity.
In one of the several published human
studies, Bush et al. (1986) analyzed 170 semen
samples for PCBs and p,p´-DDE from fertile
men, men with idiopathic oligospermia, and
men postvasectomy. The mean (SE) of ΣPCBs
in the semen samples was 5.8 ng/g (0.8). The
authors stated that these concentrations were
consistent with levels seen in the general popu-
lation; the semen sample PCB concentrations
were of comparable concentration to residues in
human blood. In men with a sperm count < 20
million/mL, there was a signiﬁcant inverse rela-
tionship between sperm motility and the con-
centration of PCBs 153, 138, and 118, three
congeners that are found in a large proportion
of the general population (Bush et al. 1984).
In a recently published study, Dallinga et
al. (2002) explored the relationship between
human semen quality and organochlorine com-
pounds in blood and semen. Among 65 men
selected from couples visiting the Maastricht
University Hospital, The Netherlands, they
selected 31 men on the basis of normal semen
quality [progressively motile sperm concentra-
tion (PMSC) ≥ 107/mL], and 34 men who
were selected based on PMSC ≤ 106/mL.
Blood samples were analyzed for PCBs 118,
138, 153, and 180 and their metabolites. They
found a weak positive relationship between
individual and combined PCB concentrations
and sperm morphology (for combined PCBs,
n = 36, R2 = 0.15, p = 0.02). Within a stratiﬁed
analysis, they found negative correlations
between combined PCB metabolites in blood
and sperm count and PMSC.
In another recently published study of 305
Swedish men 18–21 years old from the general
population, Richthoff et al. (2003) found weak
but statistically signiﬁcant negative associations
between PCB-153 and both the testosterone:
sex-hormone–binding globulin ratio and
CASA-measured sperm motility. They did not
ﬁnd associations with other semen parameters.
They did not analyze serum for other PCB
congeners. In the present study, the highest
PCB-153 tertile, compared with the lowest ter-
tile, was inversely, although not signiﬁcantly,
associated with sperm concentration, motility,
and morphology.
Although the present study was a cross-
sectional study in which semen and blood
samples were collected on the same day, the
long biologic half-life for PCBs and p,p´-DDE
(Brown 1994; Phillips et al. 1989b) and the
relatively short time interval for spermatogene-
sis (3 months) make this limitation of less
concern. When conducting a study within a
“special population,” such as an infertility
clinic, there are concerns with the generaliz-
ability of the results to the general population.
Although the men in the present study may
not be representative of men in Massachusetts,
generalizability may not necessarily be limited.
It is a misconception that generalization from a
study group depends on the study group’s
being a representative subgroup of the target
population (Rothman and Greenland 1998).
For generalizability to be limited, the men who
visit the infertility clinic would need to differ
from men in the general population at some
level that alters their response to PCBs.
Although it is possible that men who visit this
infertility clinic may differ from men in the
general population and therefore be more “sus-
ceptible” to PCBs, this does not limit the inter-
nal validity of the study. On the contrary, the
hypothesized increased susceptibility among
infertility clinic men is an advantage of the
design of the study because the most efﬁcient
way to explore whether environmental com-
pounds affect human semen parameters is to
target susceptible study populations. This
design principle is practiced in other areas of
epidemiology, such as when we study children,
the elderly, or chronically ill individuals. It is
efﬁcient to target a study population that may
be more susceptible to the exposure of interest
because the study will be more powerful.
It is estimated that approximately 10–15%
of couples in the United States are infertile
(Speroff et al. 1999). Among the men in an
infertile partnership, some are infertile or sub-
fertile, whereas others are fertile. Therefore,
the group of men presenting to the infertility
clinic represents both men with reduced fertil-
ity and fertile men in infertile partnerships.
Although the heterogeneity of the infertility
clinic patients may increase the generalizability
of the study results, the ultimate determina-
tion of generalizability awaits replication of
this study in different populations.
In general, semen studies are challenging to
conduct because participation rates are low
(Bonde et al. 1996). General-population semen
studies are the most challenging and may have
very low participation rates, making it difﬁcult
to deﬁne the distribution of semen parameters
in men from the general population. One sub-
sample of the general population that has been
studied are men attempting to conceive,
believed to be more representative of men from
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Table 7. Crude and adjusted ORs (95% CI) for below reference value sperm motility (SM)a by tertiles of
grouped PCBs.
Tertiles of PCB congener groupings p-Value
Tertile 1 Tertile 2 Tertile 3 for trend
ΣEstrogenic PCBs (group 1)
SM < 50% motile (n)2 6 3 43 7
Crude OR (95% CI) 1.00 1.52 (0.75–3.06) 1.65 (0.83–3.31) 0.2
Adjusted OR (95% CI)b 1.00 1.40 (0.68–2.87) 1.41 (0.67–2.96) 0.4
ΣDioxin-like PCBs (group 2)
SM < 50% motile (n)2 8 3 13 8
Crude OR (95% CI) 1.00 1.11 (0.55–2.22) 1.70 (0.85–3.41) 0.1
Adjusted OR (95% CI)b 1.00 0.97 (0.47–1.99) 1.49 (0.72–3.11) 0.3
ΣEnzyme-inducing PCBs (group 3)
SM < 50% motile (n)2 5 3 43 8
Crude OR (95% CI) 1.00 1.71 (0.85–3.44) 2.12 (1.05–4.27) 0.04
Adjusted OR (95% CI)b 1.00 1.56 (0.76–3.21) 1.80 (0.84–3.88) 0.1
Tertile cut points (ng/g lipid): ΣEstrogenic PCBs: 3.9–12.5, 12.6–19.4, 19.5–204.8; ΣDioxin-like PCBs: 19.6–61.0, 61.4–94.1,
94.9–518.5; ΣEnzyme-inducing PCBs: 19.7–68.6, 69.7–111.1, 114.5–829.6.
aBelow reference value for motility (SM) was deﬁned as < 50% motile. bAdjusted for age (continuous), abstinence time
(ﬁve categories: ≤ 2, 3, 4, 5, and ≥ 6 days) and smoking (current, former, and never).
Table 8. Crude and adjusted ORs (95% CI) for below reference value sperm morphology (SMPH)a by tertiles
of grouped PCBs.
Tertiles of PCB congener groupings p-Value
Tertile 1 Tertile 2 Tertile 3 for trend
ΣEstrogenic PCBs (group 1)
SMPH < 4% normal (n)1 7 1 92 2
Crude OR (95% CI) 1.00 1.30 (0.58–2.92) 1.50 (0.68–3.33) 0.3
Adjusted OR (95% CI)b 1.00 1.11 (0.47–2.61) 1.47 (0.62–3.47) 0.4
ΣDioxin-like PCBs (group 2)
SMPH < 4% normal (n)1 6 1 82 4
Crude OR (95% CI) 1.00 1.13 (0.50–2.56) 1.88 (0.84–4.19) 0.1
Adjusted OR (95% CI)b 1.00 1.01 (0.43–2.38) 1.68 (0.72–3.93) 0.2
ΣEnzyme-inducing PCBs (group 3)
SMPH < 4% normal (n)1 5 1 92 4
Crude OR (95% CI) 1.00 1.59 (0.70–3.64) 2.23 (0.99–5.00) 0.05
Adjusted OR (95% CI)b 1.00 1.33 (0.56–3.16) 1.93 (0.79–4.72) 0.1
Tertile cut points (ng/g lipid): ΣEstrogenic PCBs: 3.9–12.5, 12.6–19.4, 19.5–204.8; ΣDioxin-like PCBs: 19.6–61.0, 61.4–94.1,
94.9–518.5; ΣEnzyme-inducing PCBs: 19.7–68.6, 69.7–111.1, 114.5–829.6.
aBelow reference value for morphology (SMPH) was deﬁned as < 4% normally shaped sperm. bAdjusted for age (continuous),
abstinence time (ﬁve categories: ≤2, 3, 4, 5, and ≥6 days) and smoking (current, former, and never).the general population than infertility clinic
patients. In comparison with two recent well-
conducted studies on men attempting to con-
ceive, the percentage of men in our study with
sperm concentration below the WHO refer-
ence value (18.8%) was higher than in Finnish
men (4.5%) but similar to that found in
Danish men (17.1% and 18.4%) (Bonde et al.
1998; Jensen et al. 2000). In a study on an
unselected population, 25% of men 18–22
years old who participated in a compulsory
examination for military service had sperm
concentrations below the reference value
(Andersen et al. 2000). Comparisons across
studies and across countries are difficult
because of differences in semen analysis tech-
niques and because the role of geography on
semen parameters remains unclear.
Conclusion
There was evidence of an inverse dose–response
relationship between PCB-138 and sperm con-
centration, motility, and morphology. There
was limited evidence of an inverse relationship
of ΣPCBs and group 3 PCBs (cytochrome
P450 enzyme inducers) with sperm motility
and sperm morphology, as well as limited evi-
dence of an inverse association between
p,p´-DDE and sperm motility. The lack of a
consistent relationship among semen parame-
ters and other individual PCB congeners and
congener groups 1 and 2 may indicate a differ-
ence in spermatotoxicity between congeners.
Conversely, the associations found between
semen parameters and PCB-138, ΣPCBs, and
group 3 PCBs may be a reﬂection of conduct-
ing multiple comparisons. Data collection is
ongoing in the present study, and these analy-
ses will be rerun on a larger, more powerful
data set. The results of the present study
emphasize the need for a better understanding
of the relationship between environmental
chemicals and semen quality.
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